GL1X · GenesisL1 explorer

Research workbench

Optimization and biological evaluation of thiazole-bis-amide inverse agonists of rorgt

Analyse Optimization and biological evaluation of thiazole-bis-amide inverse agonists… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6VSW
Type
protein
Length
453 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rar-related orphan receptor C
UniProt
Q6I9R9
Ligands
RG7
Pockets
9 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARar-related orphan receptor Cprotein22868% helix, 4% strandQ6I9R9
BRar-related orphan receptor Cprotein22569% helix, 4% strandQ6I9R9

Ligands and binding sites

  • RG7 · 5-(2,3-dichloro-4-{[(2S)-1,1,1-trifluoropropan-2-yl]sulfamoyl}phenyl)-4-(4-fluoropiperidine-1-carbonyl)-N-(2-hydroxy-2-methylpropyl)-1,3-thiazole-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15080.850.9143RG7
25020.850.9140RG7
311070.790.8078empty
41320.480.7819empty
5760.380.7719empty

Interfaces

1 interface between chains.

  • A–B · 513 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 6VSW · Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORgt · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.